1. Home
  2. VNRX vs LSTA Comparison

VNRX vs LSTA Comparison

Compare VNRX & LSTA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo VolitionRX Limited

VNRX

VolitionRX Limited

HOLD

Current Price

$0.72

Market Cap

24.5M

Sector

Health Care

ML Signal

HOLD

Logo Lisata Therapeutics Inc.

LSTA

Lisata Therapeutics Inc.

HOLD

Current Price

$0.99

Market Cap

28.9M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
VNRX
LSTA
Founded
N/A
1980
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: In Vitro & In Vivo Diagnostic Substances
Misc Health and Biotechnology Services
Sector
Health Care
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
24.5M
28.9M
IPO Year
2012
2000

Fundamental Metrics

Financial Performance
Metric
VNRX
LSTA
Price
$0.72
$0.99
Analyst Decision
Strong Buy
Buy
Analyst Count
5
2
Target Price
$1.67
$15.00
AVG Volume (30 Days)
239.0K
104.8K
Earning Date
05-12-2026
05-11-2026
Dividend Yield
N/A
N/A
EPS Growth
38.00
20.42
EPS
N/A
N/A
Revenue
$1,727,384.00
$35,283,868.00
Revenue This Year
$355.66
N/A
Revenue Next Year
$849.08
N/A
P/E Ratio
N/A
N/A
Revenue Growth
40.04
56.90
52 Week Low
$0.13
$1.01
52 Week High
$3.26
$5.07

Technical Indicators

Market Signals
Indicator
VNRX
LSTA
Relative Strength Index (RSI) 23.93 14.19
Support Level $0.19 N/A
Resistance Level $1.55 $2.19
Average True Range (ATR) 0.10 0.24
MACD -0.03 -0.22
Stochastic Oscillator 4.84 0.70

Price Performance

Historical Comparison
VNRX
LSTA

About VNRX VolitionRX Limited

VolitionRX Ltd is a United States-based epigenetics company that applies its Nucleosomics platform through its subsidiaries to develop simple, easy-to-use, cost-effective blood tests to help diagnose and monitor range of life-altering diseases including some cancers and diseases associated with NETosis. The tests are based on the science of Nucleosomics, which is the practice of identifying and measuring nucleosomes in the bloodstream or other bodily fluid - an indication that disease is present. The company is focused on human diagnostics and monitoring but also has a subsidiary focused on diagnostics and monitoring.

About LSTA Lisata Therapeutics Inc.

Lisata Therapeutics Inc is a clinical-stage pharmaceutical company dedicated to the discovery, development, and commercialization of therapies for the treatment of solid tumors and other diseases. Its investigational product, certepetide, is designed to activate a novel uptake pathway that allows co-administered or tethered (i.e., molecularly bound) anti-cancer drugs to target and penetrate solid tumors more effectively. The company has one operating segment, the research and development of its investigational drug product.

Share on Social Networks: